GBI Research

At GBI Research, we leverage extensive proprietary databases and employ novel data interrogation methodologies to generate new and meaningful analyses and insights.Our content and coverage are informed by close collaboration with a global network of domain-specific external partners; this allows us to deliver novel, thought-provoking and idea-generating insights that clients would normally struggle to access.Our in-house team of researchers and analysts – typically with MBAs, PhDs and MScs, as well as considerable healthcare industry experience is located across the UK, US and Asia Pacific. The team provides expert and insightful commentary to support evidence-based analyses of established and emerging markets.

All articles by GBI Research

  1. HPV vaccines continue to dominate cancer vaccines landscape

    Cancer vaccines are a type of immunotherapy used to either treat existing cancer or prevent the development of cancer. Cancer…
    Read More…

    7 Jan
  2. The bioterrorism threat: what power can terrorists wield with microbes?

    Infectious diseases kill over 17 million people yearly and the agents that cause them are toxic, widespread and reproducible. These…
    Read More…

    4 Dec
  3. GM babies: He Jiankui and the ethics of gene editing

    In late November, Shenzhan’s Southern University of Science and Technology researcher He Jiankui announced on YouTube that his research had…
    Read More…

    3 Dec
  4. ‘Nanocarrier’ brings hope for disease-modifying osteoarthritis drugs

    Osteoarthritis is a progressive degenerative disease of the joints thought to affect over 30 million adults in the US. The…
    Read More…

    3 Dec
  5. Industry experts believe External Reference Pricing is coming to the US

    On October 25, 2018, the Trump administration proposed limiting Medicare’s spending on drugs by implementing an International Pricing Index, which…
    Read More…

    28 Nov
  6. Scorpion venom could hold the key to breaching the blood-brain barrier

    The Peptides and Proteins Lab at the Institute for Research in Biomedicine (IRB Barcelona) has published a paper in Chemical…
    Read More…

    22 Nov
  7. Waste not, want not: how exosomes went from trash to trials

    Exosomes are cell-derived vesicles that are present in almost all eukaryotic fluids, including blood, urine, cerebrospinal fluid (CSF) and cultured…
    Read More…

    6 Nov
  8. Does psychedelic microdosing have true potential in mental health?

    Micro-dosing is a growing health phenomenon involving the regular consumption of small doses of psychedelic drugs, usually a tenth of…
    Read More…

    31 Oct
  9. Xofluza: prospects for the first FDA-approved flu therapy in 20 years

    On October 20 2018, Xofluza (baloxavir marboxil) became the first medicine to achieve FDA approval for the treatment of the…
    Read More…

    31 Oct
  10. Will biosimilar launches send Humira tumbling in Europe?

    Last week, the EU saw the launch of four different biosimilars of Humira (adalimumab), the best-selling prescription drug in the…
    Read More…

    30 Oct

Go Top